Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors

(2015)   Oncotarget

The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway

(2015) Tara Karnezis et al.   Oncotarget

The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion

(2013) Mamadou Keita et al.   CELL CYCLE

Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation

(2012) Ivan Casaburi et al.   CELL CYCLE

CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth

(2012) Claudia Capparelli et al.   CELL CYCLE

Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin

(2012) Hongxi Zhao et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Management of ovarian cancer has changed

(2012) S. Alouini   GYNECOLOGIC ONCOLOGY

Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression

(2012) Mamadou Keita et al.   GYNECOLOGIC ONCOLOGY

Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription

(2012) Daniel J. Purcell et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Transcription factor Runx2 is a regulator of epithelial–mesenchymal transition and invasion in thyroid carcinomas

(2012) Dong-Feng Niu et al.   LABORATORY INVESTIGATION

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches

(2011) H. Li et al.   Cancer Prevention Research

RUNX3 functions as an oncogene in ovarian cancer

(2011) Cecilia Wei Lin Lee et al.   GYNECOLOGIC ONCOLOGY

Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines

(2011) Laurent Brard et al.   GYNECOLOGIC ONCOLOGY

Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation

(2011) K. Adam Morrow et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility

(2011) Margaretha van der Deen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

p8 Expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis

(2011) Maria Jose Sandi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The roles of P- and E-selectins and P-selectin glycoprotein ligand-1 in primary and metastatic mouse melanomas

(2011) Toshifumi Yamaoka et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

IL1α and IL4 signalling in human ovarian surface epithelial cells

(2011) Georgia Papacleovoulou et al.   JOURNAL OF ENDOCRINOLOGY

Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells

(2011) M. Mansour et al.   JOURNAL OF VIROLOGY

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer

(2011) Pierre-Luc Mercier et al.   Molecular Oncology

Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling

(2011) M-H Yang et al.   ONCOGENE

Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties

(2011) Z Huang et al.   ONCOGENE

Runx family genes, niche, and stem cell quiescence

(2010) Chelsia Qiuxia Wang et al.   BLOOD CELLS MOLECULES AND DISEASES

Runx2 in normal tissues and cancer cells: A developing story

(2010) Karen Blyth et al.   BLOOD CELLS MOLECULES AND DISEASES

Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy

(2010) A. Agarwal et al.   CANCER RESEARCH

Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4DCAF1

(2010) Wei Li et al.   CELL CYCLE

Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma☆

(2010) Jesús Planagumà et al.   HUMAN PATHOLOGY

Nupr1: The Swiss-knife of cancer

(2010) Carla E. Cano et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Minireview: Epigenetic Changes in Ovarian Cancer

(2009) Curt Balch et al.   ENDOCRINOLOGY

RUNX3 Gene Methylation in Epithelial Ovarian Cancer Tissues and Ovarian Cancer Cell Lines

(2009) Shiqian Zhang et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

(2009) J Akech et al.   ONCOGENE

Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids

(2008) Sylvain L'Espérance et al.   BMC GENOMICS

Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas

(2008) Bernard Têtu et al.   MODERN PATHOLOGY